Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta

Yohei Bamba, Masahiro Nonaka, Natsu Sasaki, Tomoko Shofuda, Daisuke Kanematsu, Hiroshi Suemizu, Yuichiro Higuchi, Ritsuko K. Pooh, Yonehiro Kanemura, Hideyuki Okano, Mami Yamasaki

Research output: Contribution to journalArticle

Abstract

Study Design: We established induced pluripotent stem cells (iPSCs) and neural stem/progenitor cells (NSPCs) from three newborns with spina bifida aperta (SBa) using clinically practical methods. Purpose: We aimed to develop stem cell lines derived from newborns with SBa for future therapeutic use. Overview of Literature: SBa is a common congenital spinal cord abnormality that causes defects in neurological and urological functions. Stem cell transplantation therapies are predicted to provide beneficial effects for patients with SBa. However, the availability of appropriate cell sources is inadequate for clinical use because of their limited accessibility and expandability, as well as ethical issues. Methods: Fibroblast cultures were established from small fragments of skin obtained from newborns with SBa during SBa repair surgery. The cultured cells were transfected with episomal plasmid vectors encoding reprogramming factors necessary for generating iPSCs. These cells were then differentiated into NSPCs by chemical compound treatment, and NSPCs were expanded using neurosphere technology. Results: We successfully generated iPSC lines from the neonatal dermal fibroblasts of three newborns with SBa. We confirmed that these lines exhibited the characteristics of human pluripotent stem cells. We successfully generated NSPCs from all SBa newbornderived iPSCs with a combination of neural induction and neurosphere technology. Conclusions: We successfully generated iPSCs and iPSC-NSPCs from surgical samples obtained from newborns with SBa with the goal of future clinical use in patients with SBa.

Original languageEnglish
Pages (from-to)870-879
Number of pages10
JournalAsian Spine Journal
Volume11
Issue number6
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Spina Bifida Cystica
Induced Pluripotent Stem Cells
Neural Stem Cells
Stem Cells
Newborn Infant
Fibroblasts
Technology
Cell Line
Pluripotent Stem Cells
Skin
Stem Cell Transplantation
Therapeutic Uses
Cell- and Tissue-Based Therapy
Ethics
Cultured Cells
Spinal Cord
Plasmids

Keywords

  • Induced pluripotent stem cells
  • Myelomeningocele
  • Neural stem/progenitor cells
  • Regenerative medicine
  • Spina bifida

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Bamba, Y., Nonaka, M., Sasaki, N., Shofuda, T., Kanematsu, D., Suemizu, H., ... Yamasaki, M. (2017). Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta. Asian Spine Journal, 11(6), 870-879. https://doi.org/10.4184/asj.2017.11.6.870

Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta. / Bamba, Yohei; Nonaka, Masahiro; Sasaki, Natsu; Shofuda, Tomoko; Kanematsu, Daisuke; Suemizu, Hiroshi; Higuchi, Yuichiro; Pooh, Ritsuko K.; Kanemura, Yonehiro; Okano, Hideyuki; Yamasaki, Mami.

In: Asian Spine Journal, Vol. 11, No. 6, 01.12.2017, p. 870-879.

Research output: Contribution to journalArticle

Bamba, Y, Nonaka, M, Sasaki, N, Shofuda, T, Kanematsu, D, Suemizu, H, Higuchi, Y, Pooh, RK, Kanemura, Y, Okano, H & Yamasaki, M 2017, 'Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta', Asian Spine Journal, vol. 11, no. 6, pp. 870-879. https://doi.org/10.4184/asj.2017.11.6.870
Bamba, Yohei ; Nonaka, Masahiro ; Sasaki, Natsu ; Shofuda, Tomoko ; Kanematsu, Daisuke ; Suemizu, Hiroshi ; Higuchi, Yuichiro ; Pooh, Ritsuko K. ; Kanemura, Yonehiro ; Okano, Hideyuki ; Yamasaki, Mami. / Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta. In: Asian Spine Journal. 2017 ; Vol. 11, No. 6. pp. 870-879.
@article{ed10064a715c443280be0657e9c88c7a,
title = "Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta",
abstract = "Study Design: We established induced pluripotent stem cells (iPSCs) and neural stem/progenitor cells (NSPCs) from three newborns with spina bifida aperta (SBa) using clinically practical methods. Purpose: We aimed to develop stem cell lines derived from newborns with SBa for future therapeutic use. Overview of Literature: SBa is a common congenital spinal cord abnormality that causes defects in neurological and urological functions. Stem cell transplantation therapies are predicted to provide beneficial effects for patients with SBa. However, the availability of appropriate cell sources is inadequate for clinical use because of their limited accessibility and expandability, as well as ethical issues. Methods: Fibroblast cultures were established from small fragments of skin obtained from newborns with SBa during SBa repair surgery. The cultured cells were transfected with episomal plasmid vectors encoding reprogramming factors necessary for generating iPSCs. These cells were then differentiated into NSPCs by chemical compound treatment, and NSPCs were expanded using neurosphere technology. Results: We successfully generated iPSC lines from the neonatal dermal fibroblasts of three newborns with SBa. We confirmed that these lines exhibited the characteristics of human pluripotent stem cells. We successfully generated NSPCs from all SBa newbornderived iPSCs with a combination of neural induction and neurosphere technology. Conclusions: We successfully generated iPSCs and iPSC-NSPCs from surgical samples obtained from newborns with SBa with the goal of future clinical use in patients with SBa.",
keywords = "Induced pluripotent stem cells, Myelomeningocele, Neural stem/progenitor cells, Regenerative medicine, Spina bifida",
author = "Yohei Bamba and Masahiro Nonaka and Natsu Sasaki and Tomoko Shofuda and Daisuke Kanematsu and Hiroshi Suemizu and Yuichiro Higuchi and Pooh, {Ritsuko K.} and Yonehiro Kanemura and Hideyuki Okano and Mami Yamasaki",
year = "2017",
month = "12",
day = "1",
doi = "10.4184/asj.2017.11.6.870",
language = "English",
volume = "11",
pages = "870--879",
journal = "Asian Spine Journal",
issn = "1976-1902",
publisher = "Korean Society of Spine Surgery",
number = "6",

}

TY - JOUR

T1 - Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with Spina bifida aperta

AU - Bamba, Yohei

AU - Nonaka, Masahiro

AU - Sasaki, Natsu

AU - Shofuda, Tomoko

AU - Kanematsu, Daisuke

AU - Suemizu, Hiroshi

AU - Higuchi, Yuichiro

AU - Pooh, Ritsuko K.

AU - Kanemura, Yonehiro

AU - Okano, Hideyuki

AU - Yamasaki, Mami

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Study Design: We established induced pluripotent stem cells (iPSCs) and neural stem/progenitor cells (NSPCs) from three newborns with spina bifida aperta (SBa) using clinically practical methods. Purpose: We aimed to develop stem cell lines derived from newborns with SBa for future therapeutic use. Overview of Literature: SBa is a common congenital spinal cord abnormality that causes defects in neurological and urological functions. Stem cell transplantation therapies are predicted to provide beneficial effects for patients with SBa. However, the availability of appropriate cell sources is inadequate for clinical use because of their limited accessibility and expandability, as well as ethical issues. Methods: Fibroblast cultures were established from small fragments of skin obtained from newborns with SBa during SBa repair surgery. The cultured cells were transfected with episomal plasmid vectors encoding reprogramming factors necessary for generating iPSCs. These cells were then differentiated into NSPCs by chemical compound treatment, and NSPCs were expanded using neurosphere technology. Results: We successfully generated iPSC lines from the neonatal dermal fibroblasts of three newborns with SBa. We confirmed that these lines exhibited the characteristics of human pluripotent stem cells. We successfully generated NSPCs from all SBa newbornderived iPSCs with a combination of neural induction and neurosphere technology. Conclusions: We successfully generated iPSCs and iPSC-NSPCs from surgical samples obtained from newborns with SBa with the goal of future clinical use in patients with SBa.

AB - Study Design: We established induced pluripotent stem cells (iPSCs) and neural stem/progenitor cells (NSPCs) from three newborns with spina bifida aperta (SBa) using clinically practical methods. Purpose: We aimed to develop stem cell lines derived from newborns with SBa for future therapeutic use. Overview of Literature: SBa is a common congenital spinal cord abnormality that causes defects in neurological and urological functions. Stem cell transplantation therapies are predicted to provide beneficial effects for patients with SBa. However, the availability of appropriate cell sources is inadequate for clinical use because of their limited accessibility and expandability, as well as ethical issues. Methods: Fibroblast cultures were established from small fragments of skin obtained from newborns with SBa during SBa repair surgery. The cultured cells were transfected with episomal plasmid vectors encoding reprogramming factors necessary for generating iPSCs. These cells were then differentiated into NSPCs by chemical compound treatment, and NSPCs were expanded using neurosphere technology. Results: We successfully generated iPSC lines from the neonatal dermal fibroblasts of three newborns with SBa. We confirmed that these lines exhibited the characteristics of human pluripotent stem cells. We successfully generated NSPCs from all SBa newbornderived iPSCs with a combination of neural induction and neurosphere technology. Conclusions: We successfully generated iPSCs and iPSC-NSPCs from surgical samples obtained from newborns with SBa with the goal of future clinical use in patients with SBa.

KW - Induced pluripotent stem cells

KW - Myelomeningocele

KW - Neural stem/progenitor cells

KW - Regenerative medicine

KW - Spina bifida

UR - http://www.scopus.com/inward/record.url?scp=85038620223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038620223&partnerID=8YFLogxK

U2 - 10.4184/asj.2017.11.6.870

DO - 10.4184/asj.2017.11.6.870

M3 - Article

VL - 11

SP - 870

EP - 879

JO - Asian Spine Journal

JF - Asian Spine Journal

SN - 1976-1902

IS - 6

ER -